Density functional calculations on meloxicam-β-cyclodextrin inclusion complexes

International Journal of Pharmaceutics

Volumn 381, Issue 2, 2009, Pages 146-152

  Snor, Walter ^a   Liedl, Elisabeth ^a   Weiss Greiler, Petra ^a   Viernstein, Helmut ^a   Wolschann, Peter ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cyclodextrin; Density functional theory; Inclusion complexation; Meloxicam; Molecular calculation

Indexed keywords

BETA CYCLODEXTRIN; MELOXICAM;

ARTICLE; CALCULATION; COMPLEX FORMATION; DENSITY; DRUG BINDING; DRUG STABILITY; DRUG STRUCTURE; ENCAPSULATION; GEOMETRY; HYDROGEN BOND; PRIORITY JOURNAL;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BETA-CYCLODEXTRINS; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG STABILITY; EXCIPIENTS; HYDROGEN BONDING; HYDROGEN-ION CONCENTRATION; ISOMERISM; MODELS, CHEMICAL; THIAZINES; THIAZOLES;

EID: 70349279930     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.05.012     Document Type: Article

References (44)

1. as of meloxicam on complexion with natural and modified cyclodextrins. Pharmazie 62 (2007) 55
2. Alcaro S., Battaglia D., and Ortuso F. Molecular modeling of β-cyclodextrin inclusion complexes with pharmaceutical compounds. ARKIVOC 107 (2004)
3. Anconi C.P.A., Nascimento Jr. C.S., Fedoce-Lopes J., Dos Santos H.F., and De Almeida W.B. Ab Initio calculations on low-energy conformers of α-cyclodextrin. J. Phys. Chem. A 111 (2007) 12127
4. Avakyan V.G., Nazarov V.B., and Voronezheva N.I. DFT and PM3 calculations of the formation enthalpies and intramolecular H-bond energies in α-, β-, and γ-cyclodextrins. Russ. J. Phys. Chem. 79 (2005) S18
5. Banerjee R., Chakraborty H., and Sarkar M. Host-guest complexation of oxicam NSAIDs with β-cyclodextrin. Biopolymers 75 (2004) 355
6. Bender M.L., and Momiyama M. Cyclodextrin Chemistry (1978), Springer, Berlin
7. Bodor N., and Buchwald P. Theoretical insights into the formation, structure, and energetics of some cyclodextrin complexes. J. Inclus. Phenom. Macromol. 44 (2002) 9
8. Boys S.F., and Bernardi F. Calculation of small molecular interactions by differences of separate total energies-some procedures with reduced errors. Mol. Phys. 19 (1970) 553
9. Brewster M.E., and Loftsson T. Cyclodextrins as pharmaceutical solubilizers. Adv. Drug Deliv. Rev. 59 (2007) 645
10. Challa R., Ahuja A., Ali J., and Khar R.K. Cyclodextrins in drug delivery: an updated review. AAPS Pharm. Sci. Technol. 6 (2005) 329
11. Charumanee S., Titwan A., Sirithunyalug J., Weiss-Greiler P., Wolschann P., Viernstein H., and Okonogi S. Thermodynamics of the encapsulation by cyclodextrins. J. Chem. Technol. Biotechnol. 81 (2006) 523
12. Connors K.A. The stability of cyclodextrin complexes in solution. Chem. Rev. 97 (1997) 1325
13. Davis M.E., and Brewster M.E. Cyclodextrin-based pharmaceutics: past, present and future. Nat. Rev. Drug Discov. 3 (2004) 1023
14. Del Valle E.M.M. Cyclodextrins and their uses: a review. Process. Biochem. 39 (2004) 1033
15. Dodziuk H. Cyclodextrins and their Complexes (2006), Wiley-VCH, Weinheim
16. Duchene D., and Wouessidjewe D. Industrial uses of cyclodextrins and their derivatives. J. Coord. Chem. 27 (1992) 223
17. In: Frömming K.H., and Szejtli J. (Eds). Cyclodextrins in Pharmacy (1994), Kluwer Academic Publishers, Dordrecht
18. Frisch M.J., Trucks G.W., Schlegel H.B., Scuseria G.E., Robb M.A., Cheeseman J.R., Zakrzewski J.A., Montgomery J.J.A., Stratmann R.E., Burant J.C., Dapprich S., Millam J.M., Daniels A.D., Kudin K.N., Strain M.C., Farkas O., Tomasi J., Barone V., Cossi M., Cammi R., Mennucci B., Pomelli C., Adamo C., Clifford S., Ochterski J., Petersson G.A., Ayala P.Y., Cui Q., Morokuma K., Malick D.K., Rabuck A.D., Raghavachari K., Foresman J.B., Cioslowski J., Ortiz J.V., Stefanov B.B., Liu G., Liashenko A., Piskorz P., Komaromi I., Gomperts R., Martin R.L., Fox D.J., Keith T., Al-Laham M.A., Peng C.Y., Nanayakkara A., Gonzalez C., Challacombe M., Gill P.M.W., Johnson B., Chen W., Wong M.W., Andres J.L., Gonzalez C., Head-Gordon M., Replogle E.S., and Pople J.A. GAUSSIAN 03, Revision C.02 (2004), Gaussian Inc., Wallingford, CT
19. Karpfen A., Liedl E., Snor W., and Wolschann P. Homodromic hydrogen bonds in low-energy conformations of single molecule cyclodextrins. J. Inclus. Phenom. Macromol. 57 (2007) 35
20. Karpfen A., Liedl L., Snor W., Viernstein H., and Weiss-Greiler P. Density functional calculations on cyclodextrins. Monatsh. Chem. 139 (2008) 363
21. Kozar T., and Venanzi C.A. Reconsidering the conformational flexibility of β-cyclodextrin. J. Mol. Struct. 395 (1997) 451
22. Lawtrakul L., Viernstein H., and Wolschann P. Molecular dynamics simulations of β-cyclodextrin in aqueous solution. Int. J. Pharm. 256 (2003) 33
23. Lebrilla C.B. The gas-phase chemistry of cyclodextrin inclusion complexes. Acc. Chem. Res. 34 (2001) 653
24. Lipkowitz K.B. Applications of computational chemistry to the study of cyclodextrins. Chem. Rev. 98 (1998) 1829
25. Liu L., and Guo Q.X. The driving forces in the inclusion complexation of cyclodextrins. J. Inclus. Phenom. Macromol. 42 (2002) 1
26. Liu L., and Guo Q.X. Use of quantum chemical methods to study cyclodextrin chemistry. J. Inclus. Phenom. Macromol. 50 (2004) 95
27. Liu L., Li X.S., Guo Q.X., and Liu Y.C. Hartree-Fock and density functional theory studies on the molecular recognition of the cyclodextrin. Chin. Chem. Lett. 10 (1999) 1053
28. Loftsson T., and Duchene D. Cyclodextrins and their pharmaceutical applications. Int. J. Pharm. 329 (2007) 1
29. Luger P., Daneck K., Engel W., Trummlitz G., and Wagner K. Structure and physicochemical properties of meloxicam, a new NSAID. Eur. J. Pharm. Sci. 4 (1996) 175
30. Naidu N.B., Chowdary K.P.R., Murthy K.V.R., Satyanarayana V., Haymanc A.R., and Becket G. Physicochemical characterization and dissolution properties of meloxicam-cyclodextrin binary systems. J. Pharmaceut. Biomed. 35 (2004) 75
31. Pinjari R.V., Joshi K.A., and Gejji S.P. Molecular electrostatic potentials and hydrogen bonding in α-, β-, and γ-cyclodextrins. J. Phys. Chem. A 110 (2006) 13037
32. Pinjari R.V., Joshi K.A., and Gejji S.P. Theoretical studies on hydrogen bonding, NMR chemical shifts and electron density topography in α, β and γ-cyclodextrin conformers. J. Phys. Chem. A 111 (2007) 13583
33. Rajewski R.A., and Stella V.J. Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery. J. Pharm. Sci. 85 (1996) 1142
34. Rekharsky M.V., and Inoue Y. Complexation thermodynamics of cyclodextrins. Chem. Rev. 98 (1998) 1875
35. Scheiner S. Hydrogen Bonding. A Theoretical Perspective (1979), University Press, Oxford
36. Snor W., Liedl E., Weiss-Greiler P., Karpfen A., Viernstein H., and Wolschann P. On the structure of anhydrous β-cyclodextrin. Chem. Phys. Lett. 441 (2007) 159
37. Szejtli J. Cyclodextrins and their Inclusion Complexes (1982), Akademiai Kiado, Budapest
38. Szejtli J. Introduction and general overview of cyclodextrin chemistry. Chem. Rev. 98 (1998) 1743
39. Szejtli J. Past, present, and future of cyclodextrin research. Pure Appl. Chem. 76 (2004) 1825
40. In: Szejtli J., and Osa T. (Eds). Comprehensive Supramolecular Chemistry: Cyclodextrins (1996), Pergamon
41. Tsai R.S., Carrupt P.A., El Tayar N., Giroud Y., Anrade P., Testa B., Bree F., and Tillement J.P. Physicochemical and structural properties of nonsteroidal anti-inflammatory oxicams. Helv. Chim. Acta 76 (1993) 842
42. Viernstein H., Weiss-Greiler P., and Wolschann P. Solubility enhancement of low soluble biologically active compounds by β-cyclodextrin and dimethyl-β-cyclodextrin. J. Inclus. Phenom. Macromol. 44 (2002) 235
43. Vyas A., and Saraf S. Cyclodextrin based novel drug delivery systems. J. Inclus. Phenom. Macromol. 62 (2008) 23
44. Weinzinger P., Weiss-Greiler P., Snor W., Viernstein H., and Wolschann P. Molecular dynamics simulations and quantum chemical calculations on β-cyclodextrin-spironolactone complex. J. Inclus. Phenom. Macromol. 57 (2007) 29